section name header

Basic Information

AUTHOR: Fred F. Ferri, MD

Definition

Acute bronchitis is a self-limited inflammation of trachea and bronchi.

Synonym

Chest cold

ICD-10CM CODE
J20.9Acute bronchitis, unspecified
Epidemiology & Demographics

  • Highest incidence in smokers, older adults, and young children and during winter months.
  • In the U.S. there are nearly 30 million ambulatory visits annually for cough, leading to more than 12 million diagnoses of “bronchitis.”
  • Acute lower respiratory tract infection is the most common condition treated in primary care.
Physical Findings & Clinical Presentations

  • In most cases, acute bronchitis begins with signs and symptoms typical of the common cold syndrome (nasal congestion, sore throat), followed shortly by the onset of cough
  • Cough, usually worse in the morning, often productive; mainly caused by transient bronchial hyperresponsiveness
  • Low-grade fever
  • Substernal discomfort worsened by coughing
  • Postnasal drip, pharyngeal injection
  • Rhonchi that may clear after cough, occasional wheezing
  • Various host factors (age, immune status, smoking, underlying medical conditions) can influence illness severity and clinical presentation
  • In mild cases, the illness lasts only 7 to 10 days, whereas in others, cough may persist for up to 3 wk or longer
Etiology

  • Viral infections are the leading cause of bronchitis (rhinovirus, influenza virus, adenovirus, respiratory syncytial virus)
  • Atypical organisms (Mycoplasma, Chlamydia pneumoniae)
  • Bacterial infections (Bordetella pertussis, Haemophilus influenzae, Moraxella, Streptococcus pneumoniae)
  • Table 1 summarizes viral and bacterial causes of acute bronchitis

TABLE 1 Viral and Bacterial Causes of Acute Bronchitis

PathogenSeasonalityComments
Influenza virusesWinterLocal epidemics last 6-8 wk during which clinical illness of cough and fever has high predictive value; laboratory diagnosis readily available; early neuraminidase inhibitor therapy effective
RhinovirusesFall and springMost frequent cause of common cold syndrome; immunity is serotype specific
CoronavirusesWinter to springCause common cold syndrome; newer strains are difficult to culture and require RT-PCR for diagnosis
AdenovirusesYear round, winter epidemicsHigh attack rates in closed populations such as persons living in military barracks or college dormitories; serotype-specific immunity
Respiratory syncytial virus (RSV)Late fall to early springAttack rates approach 75% in neonates, 3%-5% in adults; associated with wheezing in all age groups; rapid antigen test accurate in children but requires culture or RT-PCR to diagnose in adults
Human metapneumovirus (hMPV)Winter to early springAssociated with wheezing in adults and in infants; difficult to isolate in tissue culture and often requires RT-PCR
Parainfluenza virusesFall to winterSimilar to RSV and hMPV, parainfluenza viruses are primarily pediatric pathogens but can cause severe acute disease in some adults
Measles virusYear roundCan cause respiratory disease in malnourished children; illness causes transient immune suppression
Mycoplasma pneumoniaeYear round, fall outbreaksLong incubation period (10-21 days) results in staggered epidemic pattern in families; nonproductive persistent cough typical; diagnosed by IgM serology; treated with macrolide, quinolone, or tetracycline antibiotics
Chlamydia pneumoniaeYear roundAssociated with sinusitis; diagnosis by RT-PCR not readily available
Bordetella pertussisYear roundSevere illness in nonimmunized children; illness milder in partially immune adults; can be associated with prolonged cough; adults are often reservoirs for epidemics; early therapy with antibiotics can reduce spread

IgM, Immunoglobulin M; RT-PCR, reverse-transcriptase polymerase chain reaction.

From Bennett JE et al: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, ed 8, Philadelphia, 2015, Saunders.

Diagnosis

Differential Diagnosis

  • Pneumonia
  • Asthma
  • Sinusitis
  • Bronchiolitis
  • Aspiration
  • Cystic fibrosis
  • Pharyngitis
  • Cough secondary to medications
  • Neoplasm (elderly patients)
  • Influenza
  • Allergic aspergillosis
  • Gastroesophageal reflux disease
  • Congestive heart failure (in elderly patients)
  • Bronchogenic neoplasm
Workup

Seldom necessary (e.g., to rule out pneumonia, neoplasm)

Laboratory Tests

Laboratory tests are generally not necessary.

Imaging Studies

Chest x-ray is usually reserved for patients with suspected pneumonia, influenza, or underlying chronic obstructive pulmonary disease (COPD) and no improvement with therapy.

Treatment

Nonpharmacologic Therapy

  • Avoidance of tobacco and other pulmonary irritants
  • Increased fluid intake
  • Use of vaporizer to increase room humidity
Acute General Rx

  • Therapy is generally symptomatic and directed at relief of cough and wheezing.
  • Inhaled bronchodilators (e.g., albuterol, metaproterenol) as needed for 1 to 2 wk in patients with wheezing or troublesome cough. Inhaled albuterol has been proven effective in reducing the duration of cough in adults with uncomplicated acute bronchitis.
  • Cough suppression with dextromethorphan and guaifenesin is commonly recommended; addition of codeine for cough suppression if cough is severe and is significantly interrupting patient’s sleep pattern.
  • Use of antibiotics (trimethoprim-sulfametho-xazole, amoxicillin, doxycycline, cefuroxime) for acute bronchitis is generally not indicated; should be considered only in patients with concomitant COPD, increased dyspnea, and purulent sputum or in patients with suspected pertussis. In the few cases of acute bronchitis caused by B. pertussis or atypical bacteria such as C. pneumoniae or Mycoplasma pneumoniae, early use of macrolide antibiotics is reasonable. Clinicians should limit antibiotic treatment duration to 5 days when managing patients with COPD exacerbations and acute uncomplicated bronchitis who have clinical signs of a bacteria infection.
  • Antibiotics are overused in patients with acute bronchitis (70% to 90% of office visits for acute bronchitis result in treatment with antibiotics); this practice pattern is contributing to increases in resistant organisms.
  • Trials have shown that there are no significant differences in patients receiving antibiotics compared with those receiving placebo in overall clinical improvements or limitations in work or other activities. There was a significant increase in adverse effects in the antibiotic group, particularly GI symptoms.
Chronic Rx

Avoidance of tobacco and other pulmonary irritants.

Disposition

  • Complete recovery within 7 to 10 days in most patients.
  • Patients should be informed to expect to have a cough for 10 to 14 days after the visit.
Referral

For pulmonary function testing only in patients with recurrent bronchitis and suspected underlying pulmonary disease.

Pearls & Considerations

Comments

  • Patients are more likely to receive prescriptions for antibiotics from mid- or late-career physicians with high patient volumes and from physicians who were trained outside of Canada or the U.S. Intervention studies reveal that patient and physician education are effective in reducing the use of antibiotic therapy. No offer or delayed offer of antibiotics for acute uncomplicated lower respiratory tract infection is acceptable, is associated with little difference in symptom resolution, and is likely to reduce antibiotic use and beliefs in the effectiveness of antibiotics.
  • It is helpful to refer to acute bronchitis as a “chest cold.” Patients should be informed that antibiotics are probably not going to be beneficial and may result in significant side effects.
Related Content

Acute Bronchitis (Patient Information)

Suggested Readings

    1. Silverman M. : Antibiotic prescribing for nonbacterial acute upper respiratory infections in elderly personsAnn Intern Med. ;166:765-774, 2017.
    2. Smith S.M. : Antibiotics for acute bronchitisJAMA. ;312, 2014.